Dr. Darweish obtained her Bachelor of Pharmacy in 2006 and a Master’s in Pharmaceutical Technology in 2010 from the University of Jordan, specializing in the Development and Response Surface Optimization of extended-release dosage form. With over 18 years of extensive experience in the pharmaceutical sector, her expertise lies predominantly in Research and Development across various pharmaceutical dosage forms. This encompasses pre-formulation, formulation, optimization, development, and scale-up processes to ensure formulations’ stability, bioequivalence, manufacturing, efficacy, and safety.
Dr. Darweish is presently serving as the Corporate Research and Development Manager at Tabuk Pharmaceutical Company.